Personnel

Ashleigh Palmer named new chief business officer at biotech company

Published in Cancer Weekly, March 9th, 2004

Can-Fite BioPharma announced that Ashleigh Palmer has been appointed the company's new chief business officer in charge of U.S. corporate development.

Can-Fite develops innovative treatments for cancer and inflammatory diseases. The company is currently engaged in two multicenter phase II trials of its drug CF101 for the treatment of colorectal cancer and rheumatoid arthritis. It is also planning to initiate a phase I/II trial of CF101 in combination with chemotherapy in the U.S. in Q2 2004.

Palmer joins an existing U.S. management team that includes a VP of Drug Development, William Kerns, and a medical director, Michael H. Silverman....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-03-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry